Function of IRAG and the phosphorylation of the InsP3R-I for the NO/cGMP-dependent inhibition of platelet aggregation
BMC Pharmacology volume 11, Article number: P58 (2011)
Precondition for activation and aggregation of platelets is a rise in intracellular calcium concentration which can be inhibited by activation of the NO/cGMP/cGKI signalling cascade. The cGMP-dependent Kinase I (cGKI) is assembled in a macrocomplex with the Inositoltrisphosphate receptor I (InsP3R-I) and the Inositoltrisphosphate receptor associated cGMP kinase substrate (IRAG).
We investigated the relevance of IRAG and the cGKI stimulated phosphorylation of the calcium channel InsP3R-I for the NO/cGMP-dependent inhibition of platelet aggregation and adhesion.
After incubation with different agonists (collagen, thrombin, TxA2) we performed aggregation experiments with platelets of WT and IRAG-KO mice, thereby the IRAG-KO platelets aggregated stronger than the WT platelets. After preincubation with NO/cGMP the inhibition of aggregation was decreased in IRAG-KO platelets compared to WT platelets. Furthermore, GPIIb/IIIa-mediated adhesion of platelets to fibrinogen could only weakly be inhibited in IRAG-deficient platelets contrary to WT platelets. The cGKI-mediated stimulation of InsP3R-I phosphorylation showed an equal increase in WT and IRAG-KO platelets.
These results revealed that IRAG plays an important role in the NO/cGMP-dependent inhibition of platelet aggregation. However, the cGMP-stimulated phosphorylation of InsP3R-I is not necessary for the inhibition of platelet aggregation.
About this article
Cite this article
Salb, K., Schinner, E. & Schlossmann, J. Function of IRAG and the phosphorylation of the InsP3R-I for the NO/cGMP-dependent inhibition of platelet aggregation. BMC Pharmacol 11 (Suppl 1), P58 (2011). https://doi.org/10.1186/1471-2210-11-S1-P58